Short Version - How Cannabinoids fight Cancer and the Possible Role of Dharmanol in the Battle.
Berkeley Bio-Organic Research Laboratories
October 25, 2013
GoldNApel 10-25-13
Jon Dough asked: “Dave, we appreciate the detailed answers. But could you give us the short version on treating cancer with cannabis and Dharmanol in particular? Thanks. Jon.”
Sure thing, though concise writing is harder for me than explaining it all in detail … but I will give it a shot.
Cannabis medicine has been shown in quality research to fight cancer with many different mechanisms. Some of these are:
1) Small doses of cannabinoids, on a regular basis, stimulate the body’s own endocannabinoid system, which, in turn, activates many of the body’s own disease-fighting mechanisms.
2) Cannabinoid therapy creates an appetite in advanced cancer patients who are battling wasting syndrome, and cannot otherwise eat.
3) Cannabinoid medicine promotes a process called apoptosis, which is the normal programmed death of a healthy cell, as opposed to continuing to live past when it should and becoming malignant.
4) Cannabinoids greatly inhibit the spreading of cancer from one organ to another.
5) When cannabinoids are used to treat malignant cell growth that is adjacent to healthy tissue, the bad cells are killed while the healthy cells are strengthened.
6) Cannabinoid therapy treats pain and nausea associated with the disease, and the side effects of the conventional treatments that are currently employed.
7) Cannabinoid therapy increased the lifespan of lab rats implanted with tumors by 36% in the first US Govt. funded research in 1975. This was opposed to the control group of rats that received no treatment, but were implanted with the same cancers.
The great bulk of the research done to date has used doses somewhat equivalent to those used in humans. The gram of oil daily recommended in Simpson therapy is a huge dose, equivalent to about 100 marijuana joints in psychoactivity, and is the most cannabis that most humans can tolerate. Even so, this dose is far less than one one-thousandth of the LD-50 (lethal dose).
The Dharmanol™ line of all-natural nutritional supplements now being developed is centered around a proprietary technology developed by Berkeley Bio that extracts and stabilizes the entire array of cannabinoids in marijuana/hemp in their non-psychoactive form. This allows a patient who cannot tolerate Simpson therapy to take the required gram of cannabinoids daily, with no psychoactive effects.
Perhaps more exciting is the fact that with this new technology one can consume many times the recommended Simpson dose of cannabinoids, also with no psychoactivity. The overwhelmingly positive anecdotal evidence we have seen as a result of Mr. Simpson’s videos on the internet has come from using a very tiny dose of cannabinoids (compared to the amounts that can cause any physiological harm.)
While I will never use the word “cure” until we have double-blind placebo-controlled tests, I thoroughly believe that the science has already shown that tiny doses are effective, many of the mechanisms are dosage-dependent, cannabis is the safest therapeutically-active drug known to man, and the mega-doses now possible with Dharmanol™-based cannabinoid products could show spectacular results.
Hope this helps.
Dave
AI
